14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Parkinsonian Disorders in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, X | 1 |
| Wu, Q | 1 |
| Lin, L | 1 |
| Sun, A | 1 |
| Liu, S | 1 |
| Li, X | 1 |
| Cao, X | 1 |
| Gao, T | 1 |
| Luo, P | 1 |
| Zhu, X | 1 |
| Wang, X | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Beha | 2015 |